Get the Stockscreener App
1.00
3.09%
0.03
Envveno Medical Corporation stock is traded at $1.00, with a volume of 4.98M.
It is up +3.09% in the last 24 hours and down -79.34% over the past month.
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
See More
Previous Close:
$0.97
Open:
$0.978
24h Volume:
4.98M
Relative Volume:
17.55
Market Cap:
$19.25M
Revenue:
-
Net Income/Loss:
$-24.05M
P/E Ratio:
-0.4651
EPS:
-2.15
Net Cash Flow:
$-17.78M
1W Performance:
-79.63%
1M Performance:
-79.34%
6M Performance:
-73.47%
1Y Performance:
-81.45%
1-Day Range:
$0.9512
$1.12
1-Week Range:
$0.90
$5.09
52-Week Range:
$0.90
$5.70
Envveno Medical Corporation Stock (NVNO) Company Profile
Name
Envveno Medical Corporation
Sector
Industry
Phone
949-261-2900
Address
70 DOPPLER, IRVINE
Compare NVNO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
1.00 | 96.14M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Envveno Medical Corporation Stock (NVNO) Latest News
Midday Stock Roundup: enVVeno Medical plunges 71% - Orange County Business Journal
This Medical Device Stock Just Plunged A Whopping 71% Today – Do You Own It? - Stocktwits
EnVVeno Medical shares fall 71.12% intraday after FDA issues not-approvable letter for VenoValve. - AInvest
EnVVeno Medical Receives Not-Approvable Letter from FDA for VenoValve, Shares Plummet 70% - AInvest
NVNO Plummets 71% After FDA Rejects VenoValve PMA—What’s Next for enVVeno? - AInvest
enVVeno tanks after FDA rejects VenoValve approval (NVNO:NASDAQ) - Seeking Alpha
Why Is EnVVeno Medical Stock (NVNO) Down 70% Today? - TipRanks
enVVeno Medical Plunges 71.6% After FDA Rejection - AInvest
enVVeno Medical receives not-approvable letter from the FDA for VenoValve - TipRanks
enVVeno Medical Plunges 76.63% After FDA Rejection - AInvest
enVVeno Medical Plunges 77.78% After FDA Rejection - AInvest
enVVeno Medical stock plummets after FDA rejects VenoValve approval - Investing.com
enVVeno Medical Receives FDA Setback for VenoValve - TipRanks
FDA rejects enVVeno Medical’s VenoValve for chronic venous insufficiency - Investing.com
enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R) - ACCESS Newswire
FDA Rejects First-Ever Surgical Venous Valve Treatment: enVVeno's VenoValve Hits Regulatory Roadblock - Stock Titan
Trend analysis for enVVeno Medical Corporation this week2025 Trading Recap & Technical Entry and Exit Alerts - Newser
Signal strength of enVVeno Medical Corporation stock in tech scanners2025 Major Catalysts & Real-Time Sentiment Analysis - Newser
Quant Strategy Flags enVVeno Medical Corporation for EntryJuly 2025 Volume & Risk Managed Investment Signals - Newser
Published on: 2025-08-19 23:43:17 - Newser
Heavy Losses Hit James Hardie, EnVVeno And Calidi Shares - Finimize
Is now a turning point for enVVeno Medical Corporation2025 Breakouts & Breakdowns & Advanced Technical Signal Analysis - Newser
Understanding enVVeno Medical Corporation’s price movementMarket Sentiment Review & Real-Time Volume Trigger Notifications - Newser
enVVeno Medical to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech - The Florida Times-Union
enVVeno Medical Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Newport Daily News
Is enVVeno Medical Corporation trending in predictive chart modelsJuly 2025 EndofMonth & Daily Profit Focused Screening - Newser
enVVeno Medical to Present at Webull Financial Corporate Connect Webinar on Deep Venous Disease Treatment - AInvest
Key metrics from enVVeno Medical Corporation’s quarterly dataTrade Analysis Summary & Safe Capital Growth Tips - Newser
How high can enVVeno Medical Corporation stock goJuly 2025 Drop Watch & Fast Moving Trade Plans - Newser
Tick level data insight on enVVeno Medical Corporation volatility2025 Support & Resistance & Fast Entry Momentum Alerts - Newser
Can volume confirm reversal in enVVeno Medical CorporationPortfolio Performance Report & Low Drawdown Momentum Trade Ideas - Newser
What makes enVVeno Medical Corporation stock price move sharplyTrade Risk Assessment & Advanced Swing Trade Entry Plans - Newser
How to forecast enVVeno Medical Corporation trends using time seriesProfit Target & Low Risk High Win Rate Stock Picks - Newser
Published on: 2025-08-16 15:22:13 - beatles.ru
XTX Topco Ltd Invests $80,000 in enVVeno Medical Corporation (NASDAQ:NVNO) - Defense World
Using flow based indicators on enVVeno Medical CorporationJuly 2025 Fed Impact & Stepwise Trade Signal Guides - Newser
enVVeno Medical's Dual-Platform Gambit: A High-Stakes Play in Venous Disease Innovation - AInvest
Deep Venous Disease Treatment Pioneer enVVeno Medical to Showcase at Webull Biotech Conference - Stock Titan
Is it too late to sell enVVeno Medical CorporationWeekly Trend Summary & Weekly High Return Stock Opportunities - Newser
Published on: 2025-08-14 14:16:22 - beatles.ru
Why enVVeno Medical Corporation stock attracts strong analyst attention2025 Investor Takeaways & Weekly Momentum Picks - Newser
Published on: 2025-08-13 13:11:19 - 선데이타임즈
Can enVVeno Medical Corporation be the next market leaderLow Float Big Mover Alerts - sisain.net
Is Now a Good Time to Reenter enVVeno Medical CorporationStock Selection With High Accuracy Based on Models - beatles.ru
How enVVeno Medical Corporation stock performs during market volatilityFree Trend Continuation Signals - newsyoung.net
Envveno Medical Corporation Stock (NVNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Envveno Medical Corporation Stock (NVNO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Gray Robert | Director |
Dec 31 '24 |
Buy |
2.94 |
3,500 |
10,290 |
11,155 |
| Shrivastava Sanjay | Director |
Dec 24 '24 |
Buy |
2.90 |
5,400 |
15,660 |
9,288 |
| Jenusaitis Matthew | Director |
Dec 19 '24 |
Buy |
2.53 |
9,620 |
24,339 |
16,545 |
| BERMAN ROBERT ANDREW | Chief Executive Officer |
Dec 19 '24 |
Buy |
2.55 |
12,000 |
30,600 |
222,236 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):